Financhill
Buy
72

DSGN Quote, Financials, Valuation and Earnings

Last price:
$9.82
Seasonality move :
-15.75%
Day range:
$9.69 - $10.31
52-week range:
$2.60 - $10.31
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.79x
Volume:
296.6K
Avg. volume:
401.6K
1-year change:
58.09%
Market cap:
$556.5M
Revenue:
--
EPS (TTM):
-$1.19

Earnings Data

Next earnings date for DSGN
Mar 10
2026
Most recent earnings per share
-$0.30
Beat by $0.04
(Nov 5/2025)
Consensus Estimate
-$0.34
(Nov 5/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

DSGN Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/10/2026 Q4 -- -- -- -$0.33 --
11/05/2025 Q3 -- -- -$0.30 -$0.34 $0.04
08/06/2025 Q2 -- -- -$0.34 -$0.33 -$0.01
05/07/2025 Q1 -- -- -$0.31 -$0.28 -$0.03
03/10/2025 Q4 -- -- -$0.24 -$0.27 $0.03
11/07/2024 Q3 -- -- -$0.23 -$0.24 $0.01
08/05/2024 Q2 -- -- -$0.21 -$0.23 $0.02
05/08/2024 Q1 -- -- -$0.20 -$0.26 $0.07
03/19/2024 Q4 -- -- -$0.21 -$0.32 $0.11
11/13/2023 Q3 -- -- -$0.28 -- --
08/14/2023 Q2 -- -- -$0.36 -- --
05/09/2023 Q1 -- -- -$0.35 -- --
03/14/2023 Q4 -- -- -$0.31 -- --
11/03/2022 Q3 -- -- -$0.32 -- --
08/08/2022 Q2 -- -- -$0.27 -- --
05/09/2022 Q1 -- -- -$0.24 -- --
03/10/2022 Q4 -- -- -$0.20 -- --
11/09/2021 Q3 -- -- -$0.21 -- --
08/09/2021 Q2 -- -- -$0.14 -- --
05/10/2021 Q1 -- -- -$0.10 -- --
12/31/2020 Q4 -- -- -$0.07 -- --
09/30/2020 Q3 -- -- -$0.04 -- --
06/30/2020 Q2 -- -- -$0.03 -- --
03/31/2020 Q1 -- -- -$0.01 -- --

Design Therapeutics, Inc. Earnings Questions

  • How Much did Design Therapeutics, Inc. Generate in Revenue Last Quarter?

    Design Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Design Therapeutics, Inc. Beat Earnings Last Quarter?

    Design Therapeutics, Inc. announced earnings per share of -$0.30 which represents a beat of analyst forecast a -$0.34 per share.

  • Is Design Therapeutics, Inc. Profitable?

    Design Therapeutics, Inc. reported -$155K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Design Therapeutics, Inc. EPS Next Year?

    Design Therapeutics, Inc.'s earnings are forecast to decrease from -$0.88 per share to -$0.90 per share next year representing a decrease of -44.93%.

  • When is Design Therapeutics, Inc.'s Earnings Date?

    Design Therapeutics, Inc.'s next earnings date is March 10, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
81
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
56
SMX alert for Dec 6

SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.

Buy
62
PRAX alert for Dec 6

Praxis Precision Medicines, Inc. [PRAX] is up 30.47% over the past day.

Sell
13
PSN alert for Dec 6

Parsons Corp. [PSN] is down 21.1% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock